Metabolic fingerprints of circulating IGF-1 and the IGF-1/IGFBP-3 Ratio: A multifluid metabolomics study

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 12, 2016, Pages 4730-4742

  Knacke, Henrike ^a   Pietzner, Maik ^a   Do, Kieu Trinh ^b   Römisch Margl, Werner ^b   Kastenmüller, Gabi ^b   Völker, Uwe ^a   Völzke, Henry ^a   Krumsiek, Jan ^b   Artati, Anna ^b   Wallaschofski, Henri ^a,d   Nauck, Matthias ^a   Suhre, Karsten ^b,e   Adamski, Jerzy ^b,c,f   Friedrich, Nele ^a,g  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^d Schwerpunktpraxis fur Diabetes und Hormonerkrankungen   (Germany)

^e WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^g Research Centre for Prevention and Health   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BETAINE; BRADYKININ; FATTY ACID DERIVATIVE; HYDROCORTISONE; PHOSPHOLIPID; PIPECOLIC ACID; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; STEROID HORMONE; IGFBP3 PROTEIN, HUMAN;

ADULT; AGED; AMINO ACID METABOLISM; ANALYTIC METHOD; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GERMANY; HUMAN; MALE; MASS SPECTROMETRY; METABOLIC FINGERPRINTING; METABOLIC SYNDROME X; METABOLOMICS; MITOCHONDRIAL RESPIRATION; MULTIFLUID METABOLOMICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; SEX DIFFERENCE; EPIDEMIOLOGY; METABOLISM; METABOLOME; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; REGISTER; YOUNG ADULT;

ADULT; AGED; FEMALE; GERMANY; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; METABOLOME; METABOLOMICS; MIDDLE AGED; REGISTRIES; SEX FACTORS; YOUNG ADULT;

EID: 85003666432     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2016-2588     Document Type: Article

References (78)

1. Brooker GJ, Kalloniatis M, Russo VC, Murphy M, Werther GA, Bartlett PF. Endogenous IGF-1 regulates the neuronal differentiation of adult stem cells. J Neurosci Res. 2000;59:332-341
2. Ojeda SR, Dissen GA. Developmental regulation of the ovary via growth factor tyrosine kinase receptors. Trends Endocrinol Metab. 1994;5:317-323
3. Sofikitis N, Giotitsas N, Tsounapi P, Baltogiannis D, Giannakis D, Pardalidis N. Hormonal regulation of spermatogenesis and spermiogenesis. J Steroid Biochem Mol Biol. 2008;109:323-330
4. Skrtic S, Wallenius V, Ekberg S, Brenzel A, Gressner AM, Jansson JO. Insulin-like growth factors stimulate expression of hepatocyte growth factor but not transforming growth factor -1 in cultured hepatic stellate cells. Endocrinology. 1997;138:4683-4689
5. Rabkin R, Schaefer F. New concepts: Growth hormone, insulin-like growth factor-I and the kidney. Growth Horm IGF Res. 2004;14: 270-276
6. Colao A. The GH-IGF-1 axis and the cardiovascular system: Clinical implications. Clin Endocrinol (Oxf). 2008;69:347-358
7. Ohlsson C, Mohan S, Sjogren K, et al. The role of liver-derived insulin-like growth factor-I. Endocr Rev. 2009;30:494-535
8. Juul A, Dalgaard P, Blum WF, et al. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: The relation to IGF-1, IGF-1I, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab. 1995;80:2534-2542
9. Lam CS, Chen MH, Lacey SM, et al. Circulating insulin-like growth factor-1 and its binding protein-3: Metabolic and genetic correlates in the community. Arterioscler Thromb Vasc Biol. 2010;30:1479-1484
10. Ren J, Anversa P. The insulin-like growth factor I system: Physiological and pathophysiological implication in cardiovascular diseases associated with metabolic syndrome. Biochem Pharmacol. 2015;93:409-417
11. Ungvari Z, Csiszar A. The emerging role of IGF-1 deficiency in cardiovascular aging: Recent advances. J Gerontol A Biol Sci Med Sci. 2012;67:599-610
12. Eggert ML, Wallaschofski H, Grotevendt A, et al. Cross-sectional and longitudinal relation of IGF1 and IGF-binding protein 3 with lipid metabolism. Eur J Endocrinol. 2014;171:9-19
13. Friedrich N, Thuesen B, Jorgensen T, et al. The association between IGF-1 and insulin resistance: A general population study in Danish adults. Diabetes Care. 2012;35:768-773
14. Burgers AM, Biermasz NR, Schoones JW, et al. Meta-analysis and dose-response metaregression: Circulating insulin-like growth factor I (IGF-1) and mortality. J Clin Endocrinol Metab. 2011;96:2912-2920
15. Roessner U, Bowne J. What is metabolomics all about?. Biotechniques. 2009;46:363-365
16. Völzke H, Alte D, Schmidt CO, et al. Cohort profile: The Study of Health in Pomerania. Int J Epidemiol. 2011;40:294-307
17. Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem. 2009;81:6656-6667
18. Dieterle F, Ross A, Schlotterbeck G, Senn H. Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. Anal Chem. 2006;78:4281-4290
19. Do KT, Kastenmuller G, Mook-Kanamori DO, et al. Networkbased approach for analyzing intra- and interfluid metabolite associations in human blood, urine, and saliva. J Proteome Res. 2015; 14:1183-1194
20. Janssen JA, Stolk RP, Pols HA, Grobbee DE, de Jong FH, Lamberts SW. Serum free IGF-1, total IGF-1, IGFBP-1 and IGFBP-3 levels in an elderly population: Relation to age and sex steroid levels. Clin Endocrinol (Oxf). 1998;48:471-478
21. Barrou Z, Charru P, Lidy C. Dehydroepiandrosterone (DHEA) and aging. Arch Gerontol Geriatr. 1997;24:233-241
22. Traish AM, Kang HP, Saad F, Guay AT. Dehydroepiandrosterone (DHEA)'a precursor steroid or an active hormone in human physiology. J Sex Med. 2011;8:2960-2982; quiz 2983
23. Jorgensen JO, Christensen JJ, Krag M, Fisker S, Ovesen P, Christiansen JS. Serum insulin-like growth factor I levels in growth hormone-deficient adults: Influence of sex steroids. Horm Res. 2004; 62(suppl 1):73-76
24. Goodman-Gruen D, Barrett-Connor E. Effect of replacement estrogen on insulin-like growth factor-I in postmenopausal women: The Rancho Bernardo Study. J Clin Endocrinol Metab. 1996;81:4268-4271
25. Rochlani Y, Pothineni NV, Mehta JL. Metabolic syndrome: Does it differ between women and men?. Cardiovasc Drugs Ther. 2015;29: 329-338
26. Gurka MJ, Vishnu A, Santen RJ, DeBoer MD. Progression of metabolic syndrome severity during the menopausal transition. J Am Heart Assoc. 2016;5
27. Gross JJ, Wellnitz O, BruckmaierRM.Cortisol secretion in response to metabolic and inflammatory challenges in dairy cows. J Anim Sci. 2015;93:3395-3401
28. Dickerson SS, Kemeny ME. Acute stressors and cortisol responses: A theoretical integration and synthesis of laboratory research. Psychol Bull. 2004;130:355-391
29. Sakayama K, Mashima N, Kidani T, Miyazaki T, Yamamoto H, Masuno H. Effect of cortisol on cell proliferation and the expression of lipoprotein lipase and vascular endothelial growth factor in a humanosteosarcoma cell line. Cancer Chemother Pharmacol. 2008; 61:471-479
30. Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: A hypothesis. J Clin Endocrinol Metab. 2009; 94:2692-2701
31. Brindley DN. Role of glucocorticoids and fatty acids in the impairment of lipid metabolism observed in the metabolic syndrome. Int J Obes Relat Metab Disord. 1995;19(suppl 1):S69-S75
32. Whitworth JA, Williamson PM, Mangos G, Kelly JJ. Cardiovascular consequences of cortisol excess. Vasc Health Risk Manag. 2005;1: 291-299
33. McCarthy TL, Centrella M, Canalis E. Cortisol inhibits the synthesis of insulin-like growth factor-I in skeletal cells. Endocrinology. 1990;126:1569-1575
34. Cianfarani S, Germani D, Rossi L, et al. IGF-1 and IGF-binding protein-1 are related to cortisol in human cord blood. Eur J Endocrinol. 1998;138:524-529
35. Agha A, Monson JP. Modulation of glucocorticoid metabolism by the growth hormone-IGF-1 axis. Clin Endocrinol (Oxf). 2007;66: 459-465
36. Fisker S, Jorgensen JO, Vahl N, Orskov H, Christiansen JS. Impact of gender and androgen status on IGF-1 levels in normal and GHdeficient adults. Eur J Endocrinol. 1999;141:601-608
37. Christiansen JJ, Fisker S, Gravholt CH, et al. Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-1. Eur J Endocrinol. 2005;152:719-726
38. Roelfsema F, Moolenaar AJ, FrolichM.The influence of bromocriptine and transsphenoidal surgery on urinary androgen metabolite excretion in acromegaly. Acta Endocrinol (Copenh). 1984;107: 302-311
39. Cyr M, Lepage Y, Blais C Jr, et al. Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma. Am J Physiol Heart Circ Physiol. 2001;281:H275-H283
40. Webb JG, Tan Y, Jaffa MA, Jaffa AA. Evidence for prostacyclin and cAMP upregulation by bradykinin and insulin-like growth factor 1 in vascular smooth muscle cells. J Recept Signal Transduct Res. 2010;30:61-71
41. Alric C, Pecher C, Cellier E, et al. Inhibition of IGF-1-induced Erk 1 and 2 activation and mitogenesis in mesangial cells by bradykinin. Kidney Int. 2002;62:412-421
42. Pandiella A, Meldolesi J. Reinforcement of signal generation at B2 bradykinin receptors by insulin, epidermal growth factors, and other growth factors. J Biol Chem. 1989;264:3122-3130
43. Lowe WL Jr, Yorek MA, Karpen CW, et al. Activation of protein kinase-C differentially regulates insulin-like growth factor-I and basic fibroblast growth factor messengerRNAlevels. Mol Endocrinol. 1992;6:741-752
44. Lowe WL Jr, Yorek MA, Teasdale RM. Ligands that activate protein kinase-C differ in their ability to regulate basic fibroblast growth factor and insulin-like growth factor-I messenger ribonucleic acid levels. Endocrinology. 1993;132:1593-1602
45. Divecha N, Banfic H, Irvine RF. The polyphosphoinositide cycle exists in the nuclei of Swiss 3T3 cells under the control of a receptor (for IGF-1) in the plasma membrane, and stimulation of the cycle increases nuclear diacylglycerol and apparently induces translocation of protein kinase C to the nucleus. EMBO J. 1991;10:3207-3214
46. Regoli D, Gobeil F. Kinins and peptide receptors. Biol Chem. 2016; 397:297-304
47. Apicella JM, Lee EC, Bailey BL, et al. Betaine supplementation enhances anabolic endocrine and Akt signaling in response to acute bouts of exercise. Eur J Appl Physiol. 2013;113:793-802
48. Friedrich N, Nauck M, Schipf S, Volzke H, Brabant G, Wallaschofski H. Cross-sectional and longitudinal associations between insulin-like growth factor I and metabolic syndrome: A general population study in German adults. Diabetes Metab Res Rev. 2013;29: 452-462
49. Friedrich N, Haring R, Nauck M, et al. Mortality and serum insulinlike growth factor (IGF)-I and IGF binding protein 3 concentrations. J Clin Endocrinol Metab. 2009;94:1732-1739
50. Ueland PM. Choline and betaine in health and disease. J Inherit Metab Dis. 2011;34:3-15
51. Konstantinova SV, Tell GS, Vollset SE, Nygard O, Bleie O, Ueland PM. Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women. J Nutr. 2008;138:914-920
52. Lever M, Slow S. The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism. Clin Biochem. 2010; 43:732-744
53. Ji C, Kaplowitz N. Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology. 2003;124:1488-1499
54. Lee MS, Kim MS, Park SY, Kang CW. Effects of betaine on ethanolstimulated secretion of IGF-1 and IGFBP-1 in rat primary hepatocytes: Involvement of p42/44 MAPK activation. World J Gastroenterol. 2006;12:1718-1722
55. Cholewa JM, Guimaraes-Ferreira L, Zanchi NE. Effects of betaine on performance and body composition: A review of recent findings and potential mechanisms. Amino Acids. 2014;46:1785-1793
56. Bolze MS, Reeves RD, Lindbeck FE, Elders MJ. Influence of selected amino acid deficiencies on somatomedin, growth and glycosaminoglycan metabolism in weanling rats. J Nutr. 1985;115:782-787
57. Liao SF, Wang T, Regmi N. Lysine nutrition in swine and the related monogastric animals: Muscle protein biosynthesis and beyond. Springerplus. 2015;4:147
58. Wang L, Schulz TC, Sherrer ES, et al. Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling. Blood. 2007;110:4111-4119
59. Yao W, Gu H, Zhu J, et al. Integrated plasma and urine metabolomics coupled with HPLC/QTOF-MS and chemometric analysis on potential biomarkers in liver injury and hepatoprotective effects of Er-Zhi-Wan. Anal Bioanal Chem. 2014;406:7367-7378
60. Baas JC, van de Laar R, Dorland L, et al. Plasma pipecolic acid is frequently elevated in non-peroxisomal disease. J Inherit Metab Dis. 2002;25:699-701
61. Russell-Jones DL, Umpleby AM, Hennessy TR, et al. Use of a leucine clamp to demonstrate that IGF-1 actively stimulates protein synthesis in normal humans. Am J Physiol. 1994;267:E591-E598
62. Martelli AM, Gilmour RS, Bertagnolo V, Neri LM, Manzoli L, Cocco L. Nuclear localization and signalling activity of phosphoinositidase C- in Swiss 3T3 cells. Nature. 1992;358:242-245
63. Thankamony A, Capalbo D, Marcovecchio ML, et al. Low circulating levels of IGF-1 in healthy adults are associated with reduced -cell function, increased intramyocellular lipid, and enhanced fat utilization during fasting. J Clin Endocrinol Metab. 2014;99:2198-2207
64. Dixon G, Nolan J, McClenaghan NH, Flatt PR, Newsholme P. Arachidonic acid, palmitic acid and glucose are important for the modulation of clonal pancreatic -cell insulin secretion, growth and functional integrity. Clin Sci (Lond). 2004;106:191-199
65. Lipinsky PV, Sirotin IV, Skoroglyadov AV, et al. Effects of prostaglandin E1 on callus formation in rabbits. BMC Musculoskelet Disord. 2015;16:247
66. Darghosian L, Free M, Li J, et al. Effect of -three polyunsaturated fatty acids on inflammation, oxidative stress, and recurrence of atrial fibrillation. Am J Cardiol. 2015;115:196-201
67. Shen Z, Wu M, Elson P, et al. Fatty acid composition of lysophosphatidic acid and lysophosphatidylinositol in plasma from patients with ovarian cancer and other gynecological diseases. Gynecol Oncol. 2001;83:25-30
68. Bianda TL, Hussain MA, Keller A, et al. Insulin-like growth factor-I in man enhances lipid mobilization and oxidation induced by a growth hormone pulse. Diabetologia. 1996;39:961-969
69. Liang G, Cline GW, Macica CM. IGF-1 stimulates de novo fatty acid biosynthesis by Schwann cells during myelination. Glia. 2007;55: 632-641
70. Lai HC, Liu TJ, Ting CT, Sharma PM, Wang PH. Insulin-like growth factor-1 prevents loss of electrochemical gradient in cardiac muscle mitochondria via activation of PI 3 kinase/Akt pathway. Mol Cell Endocrinol. 2003;205:99-106
71. Pi Y, Goldenthal MJ, Marin-Garcia J. Mitochondrial involvement in IGF-1 induced protection of cardiomyocytes against hypoxia/reoxygenation injury. Mol Cell Biochem. 2007;301:181-189
72. Floyd S, Favre C, Lasorsa FM, et al. The insulin-like growth factor-I-mTOR signaling pathway induces the mitochondrial pyrimidine nucleotide carrier to promote cell growth. Mol Biol Cell. 2007;18: 3545-3555
73. Span JP, Pieters GF, Sweep CG, Hermus AR, Smals AG. Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: Role of sex hormone replacement. J Clin Endocrinol Metab. 2000;85:1121-1125
74. Span JP, Pieters GF, Sweep FG, Hermus AR, Smals AG. Gender differences in rhGH-induced changes in body composition in GHdeficient adults. J Clin Endocrinol Metab. 2001;86:4161-4165
75. Unden AL, Elofsson S, Brismar K. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: A population-based study. Clin Endocrinol (Oxf). 2005; 63:94-102
76. Krumsiek J, Mittelstrass K, Do KT, et al. Gender-specific pathway differences in the human serum metabolome. Metabolomics. 2015; 11:1815-1833
77. Kursa MB, Rudnicki WR. Feature selection with the boruta package. J Stat Softw. 2010;36:1-13
78. Morselli E, Frank AP, Santos RS, Fatima LA, Palmer BF, Clegg DJ. Sex and gender: Critical variables in pre-clinical and clinical medical research. Cell Metab. 2016;24:203-209